neurology Archive
-
July 11, 2022
A speedier treatment for depression?
Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder. -
July 15, 2021
Arterial stiffening linked to Alzheimer’s disease
A research team from Vanderbilt University Medical Center reports in Neurology that greater stiffening of the aorta, the main artery in the human body, is associated in older adults with increased Alzheimer’s disease (AD) pathology as reflected in a range of neurochemical indicators measured in cerebrospinal fluid. -
June 3, 2021
VUMC team discovers new genetic disease
Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting. -
June 6, 2019
Treating core Rett syndrome symptoms
A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents. -
May 16, 2019
Carly Schroeder had a stroke in her 20s. Now 10 years later, she is thankful for her life, her family and the care she received at Vanderbilt
"I'm eternally grateful to all the people that helped me through that dark time." -
March 21, 2019
Small vessel disease MRI marker linked to worse cognitive health in older adults
Enlarged perivascular spaces, which are commonly seen on brain MRIs in older adults, have important associations with worse cognitive performance, particularly information processing speed and executive function, according to a new study that challenges historical consideration that perivascular spaces are a harmless imaging marker. -
June 29, 2018
DBS treatment may slow tremor progression in early-stage Parkinson’s patients
June 29, 2018 - Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of one of the cardinal features of Parkinson’s disease.